Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
KMTS
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Kestra Medical (KMTS) Raises Outlook. Can Better Reimbursement Support Scale?
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) reported on September 14 that fiscal first-quarter 2027 revenue increased 60% to $31.0 million. Gross margin reached 56.5%, up from 45.7%, for the quarter ended July 31, 2026. Management rais…
KESTRA MEDICAL TECHNOLOGIES, LTD. Q1 2027 Earnings Call Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. Q1 2027 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why i…
Kestra targets $141M FY 2027 revenue and mid-70% gross margin in next few years as Q1 revenue reaches $31M
Earnings Call Insights: Kestra Medical Technologies (KMTS) Q1 fiscal 2027 MANAGEMENT VIEW * “Revenue advanced sequentially off a strong fourth quarter and grew 60% year-over-year to $31 million,” said (Founder, President, CEO & Director Br…
A highly anticipated Fed meeting, war worries, and an unblinking stock market: What to watch this week
If last week was the setup (consumer and wholesale inflation data, surging oil prices), then this week is the main event, with all eyes squarely on Washington, D.C., where the Federal Reserve on Wednesday will announce its latest rate deci…
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Phreesia (PHR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This…
Medtronic (MDT) Q1 Earnings and Revenues Top Estimates
Medtronic (MDT) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.26 per share a year ago. These figures are adjusted for non-recurring items. This…
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
Apple downgraded, HPE upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The…
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
Kestra Medical Technologies, Ltd. (KMTS) shares ended the last trading session 8.1% higher at $25.93. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the sto…
Kestra Secures $200M Non-Dilutive Financial To Strengthen Balance Sheet And Fuel Growth
(RTTNews) - Kestra Medical Technologies, Ltd. (KMTS) announced it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP, securing up to $200 million in non-dilutive financing. The financing includes a…
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, July 14, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Neil BhalodkarPresident and Chief Executive Officer - Brian WebsterChief Financial Officer - Vaseem Mahboob…
Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years
Earnings Call Insights: Kestra Medical Technologies (KMTS) Q4 fiscal 2026 MANAGEMENT VIEW * "We concluded fiscal 2026 with another strong quarter" and "Revenue was $28.6 million" alongside "over 6,300 prescriptions written for the ASSURE s…
Kestra Medical Technologies Q4 Earnings Call Highlights
Key Points Interested in Kestra Medical Technologies, Ltd.? Here are five stocks we like better. Revenue surged in Q4, with Kestra posting $28.6 million in revenue, up 66% year over year, while full-year fiscal 2026 revenue rose 59% to $95…
After-Hours Earnings Report for July 14, 2026 : AEHR, KMTS, EQBK, LOOP
The following companies are expected to report earnings after hours on 07/14/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Aehr Test Systems (AEHR)is reporting for the quarter ending May 31, 2026. The ele…
S&P Futures Muted as Investors Weigh Big Bank Earnings, U.S. Inflation Data and Warsh’s Testimony in Focus
September S&P 500 E-Mini futures (ESU26) are down -0.06% this morning as investors digest earnings reports from big U.S. banks, with the focus now turning to key U.S. inflation data and Federal Reserve Chairman Kevin Warsh's congressional…
What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains
On June 15, 2026, Brian Daniel Webster reported the direct sale of 15,000 common shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 15,000 Tran…
What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains
Key Points Webster sold 15,000 common shares for a total transaction value of approximately $312,000 on June 15, 2026. This sale represented 3.65% of Webster's direct common share holdings prior to the transaction, reducing his direct owne…
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
Omega Fund Management disclosed a buy of 187,500 shares of Bicara Therapeutics(NASDAQ:BCAX) in a May 15, 2026, SEC filing, with the estimated transaction value at $3.23 million based on quarterly average pricing. What happened According to…
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
On May 15, 2026, Omega Fund Management disclosed in an SEC filing that it sold 411,968 shares of Alumis(NASDAQ:ALMS), with the estimated transaction value at $10.3 million based on quarterly average pricing. What happened According to its…
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
Omega Fund Management cut its stake in Kestra Medical Technologies (NASDAQ:KMTS), selling 351,442 shares in the first quarter for an estimated $8.28 million based on quarterly average pricing, according to a May 15, 2026, SEC filing. What…
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock
Key Points Director Raymond W. Cohen acquired 10,000 shares for a transaction value of approximately $200,000 on March 26, 2026. This buy increased direct ownership by 24.45% to 50,903 shares, representing 0.087% of outstanding shares post…
KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary - Moby Strategic Performance Drivers Revenue grew 63% year-over-year, driven by a 58% increase in prescriptions and improved revenue per fit from a higher mix of in-network pa…
Kestra raises 2026 revenue guidance to $93M while advancing market expansion and margin gains
Earnings Call Insights: Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 MANAGEMENT VIEW * Brian Webster, Founder, President, CEO & Director, opened by highlighting "the strong financial performance we had in the third quarter and the cont…
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery
Kestra Medical Technologies, Ltd.KMTS announced a collaboration with Biobeat Technologies, Ltd. to improve patient monitoring and diagnosis insights for people who rely on the ASSURE Wearable Cardioverter Defibrillator (WCD) during cardiac…
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery
KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced a strategic collaboration with Biobeat Technologies, Ltd…
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on…
Kestra raises FY26 revenue guidance to $91M while targeting 70%+ gross margins with ASSURE system expansion
Earnings Call Insights: Kestra Medical Technologies (KMTS) Q2 2026 MANAGEMENT VIEW * Brian Webster, President and CEO, highlighted strong financial performance in Q2, noting "revenue was $22.6 million with growth of 53% over the prior year…
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results
KIRKLAND, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report second quarter fiscal 2026 financial results…
Kestra Prices Upsized Primary Public Offering Of Common Shares At $23 Each
(RTTNews) - Kestra Medical Technologies, Ltd. (KMTS) has priced an upsized underwritten public offering of 6 million common shares at $23.00 each. This offering, led by bookrunners BofA Securities, Piper Sandler, J.P. Morgan, Goldman Sachs…
* Wearable medical device and digital healthcare company Kestra Medical Technologies (KMTS [https://seekingalpha.com/symbol/KMTS]) priced [https://seekingalpha.com/pr/20326598-kestra-medical-technologies-ltd-announces-pricing-of-upsized-pr…
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares
KIRKLAND, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced the pricing of its upsized underwritten public offering of 6,000…
Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares
KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced an underwritten public offering of 5,500,000 common shares. Kest…
Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results
KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026…
Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE Device
KIRKLAND, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ASSURE® WCD Clinical Evaluation Post-Ap…
Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management
KIRKLAND, Wash., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced its debut at the 2025 Heart Failure Society of America (HFSA) A…
Stock Indexes Near Record Highs on Fed Rate Cut Expectations
The S&P 500 Index ($SPX) (SPY) today is up +0.09%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.31%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.37%. September E-mini S&P futures (ESU25) are up +0.06%, and September E-mini…
Stock Indexes Near Record Highs on Fed Rate Cut Expectations
The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.09%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q…